None of the treatments had any effect on CD40, CD80, or CD86 expression on DCs isolated from the tumor (Figure 7I–K) while the combination treatment significantly increased the MHC I antigen presentation on these cells (Figure 7L). This evidence concerns the gene CD40 and neoplasm.